The European Prevention of Alzheimer’s dementia (EPAD) Initiative is a collaborative research initiative to improve the chance of successfully preventing...
Read moreHydra Biosciences, Inc., a leader in the field of transient receptor potential (TRP) channel modulation, and Boehringer Ingelheim today announced...
Read moreEureka Therapeutics Inc. and Boehringer Ingelheim announced today that they have entered into a research agreement for the discovery of...
Read moreAlcon transforms eye care possibilities into therapeutic realities through the discovery and development of innovative eye care products and treatments....
Read moreAllergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Kythera...
Read moreAllergan, plc (NYSE: AGN) is pleased to announce that KYBELLA® (deoxycholic acid) injection, the first and only FDA-approved injectable treatment...
Read moreGencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs...
Read moreTakeda Pharmaceutical Company Limited (TSE: 4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development...
Read moreU.S. FDA latest regulatory authority to approve SPIRIVA® (tiotropium) Respimat® in asthma1 following authorities in the EU, Japan and other...
Read moreJardiance® achieved superiority for the primary CV endpoint and a significant reduction in CV death in people with T2D at...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
